Compound Summary
Snc 80
Compound Information
Snc 80
Compound Name: | Snc 80 |
Compound CID: | 123924 |
Synonyms: | Snc 80 156727-74-1 Snc-80 SNC80 UNII-L842QB22SW More... |
Iupac Name: | 4-[(R)-[(2S,5R)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide |
InChI: | InChI=1S/C28H39N3O2/c1-7-17-30-19-22(5)31(20-21(30)4)27(25-11-10-12-26(18-25)33-6)23-13-15-24(16-14-23)28(32)29(8-2)9-3/h7,10-16,18,21-22,27H,1,8-9,17,19-20H2,2-6H3/t21-,22+,27-/m1/s1 |
InChIKey: | KQWVAUSXZDRQPZ-UMTXDNHDSA-N |
Canonical Smiles: | CCN(CC)C(=O)C1=CC=C(C=C1)C(C2=CC(=CC=C2)OC)N3CC(N(CC3C)CC=C)C |
Isomeric Smiles: | CCN(CC)C(=O)C1=CC=C(C=C1)[C@H](C2=CC(=CC=C2)OC)N3C[C@H](N(C[C@@H]3C)CC=C)C |
Molecular Weight: | 449.6 |
Molecular Formula: | C28H39N3O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Snc 80
Molecular Weight: | 449.6 |
Molecular Formula: | C28H39N3O2 |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 9 |
Heavy Atom Count: | 33 |
Complexity: | 614 |
Synonyms
Snc 80
| Snc 80 | Snc 80 |
|---|---|
Snc 80 |
156727-74-1 |
Snc-80 |
SNC80 |
UNII-L842QB22SW |
CHEMBL13470 |
4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide |
L842QB22SW |
4-(R)-(2S,5R)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl-(3-methoxyphenyl)methyl-N,N-diethylbenzamide |
NSC707484 |
NCGC00024777-02 |
DSSTox_CID_25662 |
DSSTox_RID_81039 |
DSSTox_GSID_45662 |
(+)-4-(alphaR)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl-N,N-diethylbenzamide |
4-(R)-((2S,5R)-4-Allyl-2,5-dimethyl-piperazin-1-yl)-(3-methoxy-phenyl)-methyl-N,N-diethyl-benzamide |
Benzamide, 4-(R)-(2S,5R)-2,5-dimethyl-4-(2-propen-1-yl)-1-piperazinyl(3-methoxyphenyl)methyl-N,N-diethyl- |
CAS-156727-74-1 |
Tocris-0764 |
4-((2,5-Dimethyl-4-(2-propenyl)-1-piperazinyl)(3-methoxyphenyl)methyl)-N,N-diethylbenzamide (2S-(1(S*),2alpha,5beta))- |
SCHEMBL724753 |
GTPL1611 |
DTXSID6045662 |
CHEBI:109556 |
HMS3266B16 |
HMS3411H19 |
HMS3675H19 |
Tox21_110925 |
BDBM50039029 |
MFCD00672673 |
ZINC22066510 |
AKOS024458637 |
Tox21_110925_1 |
AT27894 |
NSC-707484 |
NCGC00024777-01 |
NCGC00024777-03 |
NCGC00024777-04 |
NCGC00024777-08 |
4-((R)-((2S,5R)-4-allyl-2,5-dimethylpiperazin-1-yl)(3-methoxyphenyl)methyl)-N,N-diethylbenzamide |
AS-74938 |
Benzamide, 4-((2,5-dimethyl-4-(2-propenyl)-1-piperazinyl)(3-methoxyphenyl)methyl)-N,N-diethyl-, (2S-(1(S*),2alpha,5bet))- |
NCI60_038183 |
HY-101202 |
B6441 |
CS-0020978 |
SR-01000597706 |
J-009336 |
Q7391803 |
SR-01000597706-1 |
BRD-K29546239-001-01-5 |
3-(4-Allyl-2,5-dimethyl-piperazin-1-yl)-(4-diethylcarbamoyl-phenyl)-methyl-benzoic acid |
4-(4-Allyl-2,5-dimethyl-piperazin-1-yl)-(3-methoxy-phenyl)-methyl-N,N-diethyl-benzamide |
(+)-4-((alpha R)-((2S,5R)-4-allyl-2,5-dimethylpiperazin-1-yl)(3-methoxyphenyl)methyl)-N,N-diethylbenzamide |
(+)-4-(?R)-?-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl-N,N-diethylbenzamide |
(+)-4-(alpha-R)-alpha-2S,5R-4-allyl2,5-dimethyl-1-piperazinyl-3-methoxybenzyl-N,N-diethylbenzamide |
4-((R)-((2R,5S)-4-allyl-2,5-dimethylpiperazin-1-yl)(3-methoxyphenyl)methyl)-N,N-diethylbenzamide |
4-(4-Allyl-2,5-dimethyl-piperazin-1-yl)-(3-methoxy-phenyl)-methyl-N,N-diethyl-benzamide (SNC 80) |
4-(4-Allyl-2,5-dimethyl-piperazin-1-yl)-(3-methoxy-phenyl)-methyl-N,N-diethyl-benzamide(SNC-80) |
4-(R)-((2R,5S)-4-Allyl-2,5-dimethyl-piperazin-1-yl)-(3-methoxy-phenyl)-methyl-N,N-diethyl-benzamide |
4-(R)-((R)-4-(S)-Allyl-2,5-dimethyl-piperazin-1-yl)-(3-methoxy-phenyl)-methyl-N,N-diethyl-benzamide |
4-(R)-(4-Allyl-2,5-dimethyl-piperazin-1-yl)-(3-methoxy-phenyl)-methyl-N,N-diethyl-benzamide |
4-(R)-(2S,5R)-2,5-Dimethyl-4-(2-propen-1-yl)-1-piperazinyl(3-methoxyphenyl)methyl-N,N-diethylbenzamide |
4-(R)-(2S,5R)-2,5-DIMETHYL-4-(PROP-2-EN-1-YL)PIPERAZIN-1-YL(3-METHOXYPHENYL)METHYL-N,N-DIETHYLBENZAMIDE |
4-(R)-(2S,5R)-4-allyl-2,5-dimethylpiperazin-1-yl(3-methoxyphenyl)-methyl-N,N-diethylbenzamide |
Experimental Data
Snc 80
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 2.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Snc 80
Statistics Data
Snc 80
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 2.000000000000000 | 1 | 1 |
Statistics Data Visualization
Snc 80
